These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 26398553)

  • 1. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis.
    Simunovic MP; Maberley DA
    Retina; 2015 Oct; 35(10):1931-42. PubMed ID: 26398553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
    Zhao XY; Xia S; Chen YX
    Br J Ophthalmol; 2018 Aug; 102(8):1077-1085. PubMed ID: 29246890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis.
    Fallico M; Maugeri A; Lotery A; Longo A; Bonfiglio V; Russo A; Avitabile T; Pulvirenti A; Furino C; Cennamo G; Barchitta M; Agodi A; Reibaldi M
    Acta Ophthalmol; 2021 Sep; 99(6):e795-e805. PubMed ID: 33326183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
    Pei M; Zhao X; Wan G
    Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy.
    Alsoudi AF; Wai KM; Koo E; Parikh R; Mruthyunjaya P; Rahimy E
    JAMA Ophthalmol; 2024 Oct; 142(10):972-975. PubMed ID: 39207799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials.
    Zhang ZH; Liu HY; Hernandez-Da Mota SE; Romano MR; Falavarjani KG; Ahmadieh H; Xu X; Liu K
    Am J Ophthalmol; 2013 Jul; 156(1):106-115.e2. PubMed ID: 23791371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
    Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
    di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial.
    Arevalo JF; Lasave AF; Kozak I; Al Rashaed S; Al Kahtani E; Maia M; Farah ME; Cutolo C; Brito M; Osorio C; Navarro P; Wu L; Berrocal MH; Morales-Canton V; Serrano MA; Graue-Wiechers F; Sabrosa NA; Alezzandrini AA; Gallego-Pinazo R;
    Am J Ophthalmol; 2019 Nov; 207():279-287. PubMed ID: 31095954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2011 May; (5):CD008214. PubMed ID: 21563165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.
    Roohipoor R; Sharifian E; Ghassemi F; Riazi-Esfahani M; Karkhaneh R; Fard MA; Zarei M; Modjtahedi BS; Moghimi S
    Retina; 2016 Oct; 36(10):1997-2005. PubMed ID: 27046456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal anti-vascular endothelial growth factor versus panretinal LASER photocoagulation for proliferative diabetic retinopathy: a systematic review and meta-analysis.
    Yates WB; Mammo Z; Simunovic MP
    Can J Ophthalmol; 2021 Dec; 56(6):355-363. PubMed ID: 33631120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non-high-risk proliferative diabetic retinopathy.
    Ferraz DA; Vasquez LM; Preti RC; Motta A; Sophie R; Bittencourt MG; Sepah YJ; Monteiro ML; Nguyen QD; Takahashi WY
    Retina; 2015 Feb; 35(2):280-7. PubMed ID: 25272318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
    Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ
    Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
    Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy.
    Alsoudi AF; Wai KM; Koo E; Parikh R; Mruthyunjaya P; Rahimy E
    JAMA Ophthalmol; 2024 Jul; 142(7):662-668. PubMed ID: 38842828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
    Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
    Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY.
    Su L; Ren X; Wei H; Zhao L; Zhang X; Liu J; Su C; Tan L; Li X
    Retina; 2016 May; 36(5):938-43. PubMed ID: 26630313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of anti-VEGF therapy in proliferative diabetic retinopathy.
    Jardeleza MS; Miller JW
    Semin Ophthalmol; 2009; 24(2):87-92. PubMed ID: 19373692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.